ABSTRACT
In China and abroad, Traditional Chinese Medicine (TCM) have been applied and developed. That is depended on doctors and scholars of the past dynasties to inseparable from the inheritance, protection, development, and innovation of Traditional Knowledge of Chinese Medicine. With the progress of modern society and people's awareness of traditional culture protection, people are also improving the understanding of TCM. Through the analysis of the situation and significance of the protection of Traditional Knowledge of Chinese Medicine and the development of Japanese Kampo medicines, recognized that the development of Kampo medicines ignored the source. Their original intention and purpose of protection the Traditional Knowledge of Medicine are completely different from China. The protection of Traditional Knowledge of Chinese Medicine should be in accordance with the basic national conditions, and the system of the protection of Traditional Knowledge of Chinese Medicine should be formulated and perfected to ensure the sustainable development of TCM.
ABSTRACT
Through the analysis of patent jurisprudence, it is proved that the Classical Prescription of Traditional Chinese Medicine (CPTCM) belongs to the scope of "existing technology" in the Law of Patent, and has lost the foundation of obtaining patent rights. Taking Japan's CPTCM as an example, based on the analysis of the administration of CPTCM and patent applications related to CPTCM in Japan, it is proved that CPTCM can not obtain patent authorization in Japan. Through the comparison of patent in China, the United States, Europe and worldwide region, it is proved that China is still the main source of patent applications for Traditional Chinese Medicine. At the end of the article, the author puts forward the suggestion of "active protection". It is believed that we should abandon the concept of patent-only protection and improve the influence of Traditional Chinese Medicine in worldwide from the aspects of industrial development, promotion ofits application, and intellectual property protection.
ABSTRACT
The common Japanese Kampo medicine issued by MHLW was sorted and analyzed, record total ingredients, average dosage, total dosage of general prescription, maximal and minimal dosage of general prescription of Japanese Kampo was originated from the classic prescription. The ingredients of each prescription medicine was relatively less, and mostly composed of 4 to 9 ingredients. The average dosage was less, around 15-25 g and the average dosage of single drug was 3.16 g. The dose of Japanese Kampo medicine was relatively less, and it was only about 1/4 of the drug used in Chinese mainland. The reasons were related to many factors like historical evolution of Chinese prescription, the habit of taking medicine, people’s constitution of different nations and so on.
ABSTRACT
Through the analysis of patent jurisprudence, it is proved that the Classical Prescription of Traditional Chinese Medicine (CPTCM) belongs to the scope of "existing technology" in the Law of Patent, and has lost the foundation of obtaining patent rights. Taking Japan's CPTCM as an example, based on the analysis of the administration of CPTCM and patent applications related to CPTCM in Japan, it is proved that CPTCM can not obtain patent authorization in Japan. Through the comparison of patent in China, the United States, Europe and worldwide region, it is proved that China is still the main source of patent applications for Traditional Chinese Medicine. At the end of the article, the author puts forward the suggestion of "active protection". It is believed that we should abandon the concept of patent-only protection and improve the influence of Traditional Chinese Medicine in worldwide from the aspects of industrial development, promotion ofits application, and intellectual property protection.
ABSTRACT
Fifty-two cases of herpes zoster were treated with acupuncture and moxibustion and a control group of 49 cases was treated with traditional Chinese medicine (Kampo). The Visual Analogue scale (VAS) was used as an index of the analgesic effects. The acupuncture and moxibustion groups were treated according to the differentiation of symptoms and signs of traditional Chinese medicine. Acupuncture was also applied around the area of affected skin, followed by 30 minutes of moxibustion. Cases in the Kampo group were given the following formulas: Ryutan-shakan-to (containing Gentianae) was administered for Damp-Heat in the Liver and Gall Bladder, Shoyosan (Pulvis ambulatorius) for Stagnation of Liver Qi and Irei-to (Formula hoelen stomachi) for Damp-Heat in the Spleen meridian. It took an average of 3.8 treatments for the pain to disappear in the 52 cases of the acupuncture group, and an average of five days for the Kampo group. Kampo was ineffective in three cases. There was a significantly higher rate of appearance of analgesic effects in the acupuncture group. Acupuncture is thought to control pain by improving the circulation of the Qi and blood. It also enhances immune function, thereby suppressing virus activity and helping reduce pain. Acupuncture and moxibustion significantly reduced pain in herpes zoster patients, and can be said to have analgesic effects.